Ardelyx CEO Michael Raab sells shares worth over $232k By Investing.com
Ardelyx, Inc. (NASDAQ:), a pharmaceutical company specializing in the development of innovative treatments, has reported a recent transaction involving its President & CEO,…
Read More...
Read More...